Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
ABACUS MEDICINE A/S
A/S
Active
Reklamebeskyttelse
CVR 28111576
Kalvebod Brygge 35, 1560
København V
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2004 · 21 years old
384 employees
www.abacusmedicine.com
Overvåg
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
ABACUS MEDICINE A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (2)
FW
Flemming Wagner
Chief Executive Officer
Chief Executive Officer
2009
PV
Per Villendrup Jenster
Founder
Founder
2004
Former (1)
JW
John Wagner
Management
Management
2004 – 2009
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (6)
SE
Sharon Evelyn Curran
Board of Directors
Board of Directors
2024
MJ
Mark Johnston
Board of Directors
Board of Directors
2019
AK
Anders Kunze Bønding
Board of Directors
Board of Directors
2019
AM
Alette Margaretha Verbeek
Board of Directors
Board of Directors
2024
JA
Jens Albert Harsaae
Chairman
Chairman
2024
TP
Troels Peter Troelsen
Board of Directors
Board of Directors
2020
Former (8)
IA
Iwan Alstrup
Board of Directors
Board of Directors
2014 – 2017
MF
Michala Fischer-Hansen
Board of Directors
Board of Directors
2021 – 2024
OJ
Ole Jensen
Board of Directors
Board of Directors
2014 – 2020
JB
Jytte Birgitte Wagner
Board of Directors
Board of Directors
2004 – 2009
LA
Lars Aaen
Board of Directors
Board of Directors
2013 – 2014
NS
Niels Smedegaard
Chairman
Chairman
2020 – 2024
LC
Lars Christian Bruhn
Chairman
Chairman
2012 – 2013
BM
Bo Michael Palm
Board of Directors
Board of Directors
2017 – 2017
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
Wagner Family Holding ApS
Company
50–66.65%
50–66.65%
2019
CHR. AUGUSTINUS FABRIKKER AKTIESELSKAB
Company
33.33–49.99%
33.33–49.99%
2019
Thorsen Ejendomme A/S
Company
25–33.32%
25–33.32%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ABACUS MEDICINE A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network